Fourth Annual Frontiers in Diabetes Research Symposium
AGENDA FOR FRONTIERS IN DIABETES RESEARCH SYMPOSIUM
Seung Kim, Director of Stanford Diabetes Research Center, Professor of Developmental Biology and Medicine (by courtesy): Medicine Grand Rounds – “Stanford Diabetes Research Center”
10:00-10:30 am Suneil Koliwad, Associate Professor, Diabetes Center, UCSF: “Translating Fat Fibrosis to Control Insulin Resistance”
10:30-10:45 am Joshua Knowles, Assistant Professor of Medicine: “Statin Associated Diabetes: Physiologic Insights”
10:45-11:00 am Joon Tae Kim, Department of Pathology: “Apolipoprotein Regulation of Endogenous PM20D1 Activity and Potential Implications for Metabolic Disease and Atherosclerosis”
11:00-11:30 am Drew Endy, Professor of Bioengineering: “Can We Engineer a Skin Microbe to Diagnose and Treat Diabetes?”
11:30-11:45 am Bruce Buckingham, Professor of Pediatrics: “Moving to a Full Closed-Loop, Removing the Daytime as Well as the Nighttime Burden of Diabetes”
11:45-12:00 pm Diana Naranjo, Clinical Associate Professor of Psychiatry and Behavioral Sciences: “Novel Interventions for Children with Special Healthcare Needs. Helping Those Who Need It Most”
2:30-3:00 pm Jon Piganelli, Associate Professor, University of Pittsburgh: "The role of oxidative stress induced inflammation in T1D"
3:00-3:15 pm Nadine Nagy, Department of Medicine: “Sustained Release of Il-2 Using an Injectable Hydrogel Prevents Autoimmune Diabetes”
3:15-3:30 pm Garry Fathman, Professor of Medicine (Emeritus): “A Novel Therapy to Restore Function of Endogenous Tregs to Prevent/Treat T1D”
3:30-4:00 pm Julie Sneddon, Assistant Professor, Diabetes Center, UCSF: "Lineage Dynamics of Pancreatic Endocrine Development at Single-Cell Resolution"
4:00-4:15 pm Linda Yip, Department of Medicine: "High Iron Exposure and Loss of Pancreatic Iron Homeostasis May Contribute to the Pathogenesis of T1D"
4:15-4:30 pm Haixia Xu, Department of Medicine: “Novel Approaches to Rescuing Insulin-Induced Hypoglycemia: Overcoming the Limitations of Glucagon”